For the two in five — or more — British adults with high cholesterol, news that a revolutionary jab could replace daily statin tablets to treat the condition is potentially very welcome. Up to 300,000 people with raised cholesterol — which means they have too much of the fatty substance in their blood and are therefore at greater risk of suffering heart disease or stroke — will receive twice-yearly jabs administered by nurses in GP surgeries over the next three years.
Experts have dubbed the medication, called inclisiran but also known as Leqvio, a game-changer that could prevent 55,000 heart attacks and strokes in a decade. The treatment has been shown to halve levels of cholesterol in as little as two weeks. But there are